期刊文献+

氟喹诺酮类抗菌药那氟沙星 被引量:4

Research Advances on Fluoroquinolone Antibiotic Nadifloxacin
下载PDF
导出
摘要 那氟沙星是日本大冢公司于20世纪80年代初研制开发的第三代喹诺酮类抗菌药。本品对革兰阳性菌、革兰阴性菌、厌氧菌和耐药菌等具有广谱抗菌活性,目前在临床上是以1%的软膏用于治疗痤疮等皮肤感染。本文比较系统地总结了那氟沙星的制备方法、药效学、毒理学、药动学和临床研究等方面的研究进展。 Nadifloxacin, developed in the early 1980s by Otsuka Pharmaceutical Co., Ltd., is a third generation of quinolone antibiotics which possesses broad-spectrum antibacterial activities against gram-positive and gram-negative bacteria, anaerobe and drug resistant bacteria etc. Current clinically used nadifloxacin in Japan is an ointment containing 1% nadifloxacin for the treatment of acne vulgaris and other dermatological infections. This review mainly summarized the preparation methods of nadifloxacin and its pharmacodynamics, toxicology, pharmacokinetics, as well as clinical studies.
出处 《国外医药(抗生素分册)》 CAS 2009年第2期68-75,共8页 World Notes on Antibiotics
关键词 那氟沙星 制备方法 药效学 毒理学 药动学 临床研究 nadifloxacin preparation pharmacodynamics toxicology pharmacokinetics clinical studies
  • 相关文献

参考文献38

  • 1Jacobs M R, Appelbaum P C. Nadifloxacin: A quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771[J]. Expert Opin Pharmacother, 2006, 7(14): 1957 被引量:1
  • 2赵文镜,曹玉峰,罗永慧,王晓梅.那氟沙星的合成[J].江苏药学与临床研究,2006,14(6):377-378. 被引量:2
  • 3颜文革,石卫兵,郭彦彰,等.8-溴-5,6-二氟-2-甲基喹啉的制备方法:CN:101016263A[P].2007-08-1 被引量:1
  • 4Hashimoto K, Okaichi Y, Nomi D, et al. A practical synthesis of (S)-(-)-nadifloxacin: novel acid-catalyzed racemization of tetrahydroquinaldine derivative[J]. Chem Pharm Bull, 1996, 44(4): 642 被引量:1
  • 5Ishikawa H, Tabusa F, Miyamoto H, et al. Studies on antibacterial agents. I. synthesis of substituted 6,7- dihydro- 1-oxo-1H,5H-benzo[i, j]-quinolizine-2- carboxylic acids[J]. Chem Pharm Bull,1989, 37(8): 2103 被引量:1
  • 6Ward K W, Lepage J F, Driot J Yo Nonclinical pharmacodynamics, pharmacokinetics, and safety of BOL- 303224-A, a novel fluoroquinolone antimicrobial agent for topical ophthalmic use[J]. J Ocul Pharmacol Ther,2007, 23(3): 243 被引量:1
  • 7Yamakawa T, Mitsuyama J, Hayashi K. In vitro and in vivo antibacterial activity of T-3921, a novel non- fluorinated topical quinolone[J]. J Antimicrobial Chemother. 2002, 49:455 被引量:1
  • 8Nenoff P, Haustein U F, Hittel N. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic gram-positive bacteria isolated from bacterial skin infections[J]. Chemotherapy, 2004, 50:196 被引量:1
  • 9Vogt K, Hahn H, Hermann J, et al. Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in ache vulgaris[J]. Drugs, 1995, 49(Suppl 2): 266 被引量:1
  • 10Vogt K, Hermann J, Blume U, et al. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris[J]. Eur J Clin Microbiol Infect Dis, 1992, 11:943 被引量:1

二级参考文献3

  • 1Hiroshi ishikawa stydies on antibacterial agents Ⅰ synthesis of substituted 6,7-dihydro-1-oxo-1H,5H-benzo[I,j]-quinolizine-2-carboxylic acids[J].Chem Pharm Bull,1989,37(8):2103~2108. 被引量:1
  • 2Otsubo,Minoru,Uchida,et al.Antibacterial activity of the metabolites of 9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo[I,j]quinolizine-2-carboxylic acid(OPC-7251)[J].Chem Pharm Bull,1990,38(7):2027~2029. 被引量:1
  • 3Koji,Hashimoto,et al.A Practical synthesis of (S)-(-)nadifioxacin:Novel acid-catalyzed racemization of tetrahydroquinaldine derivative[J].Chem Pharm Bull,1996,44(4):642~645. 被引量:1

共引文献1

同被引文献17

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部